Table 1. Clinical-pathological features of HCC patients from TCGA.
| Clinical features | Number (%) |
|---|---|
| Age in years | |
| >60 | 195 (52.3) |
| <=60 | 177 (47.5) |
| not available | 1 (0.3) |
| AJCC metastasis pathologic | |
| M0 | 267 (71.6) |
| M1 | 4 (1.1) |
| MX | 102 (27.3) |
| AJCC nodes pathologic | |
| N0 | 253 (67.8) |
| N1 | 4 (1.1) |
| NX | 115 (30.8) |
| not available | 1 (0.3) |
| AJCC tumor pathologic | |
| T1 | 182 (48.8) |
| T2 | 95 (25.2) |
| T3 | 80 (21.4) |
| T4 | 13 (3.5) |
| TX | 1 (0.3) |
| not available | 2 (0.5) |
| AJCC pathologic stage | |
| I | 172 (46.1) |
| II | 87 (23.3) |
| III | 85 (22.8) |
| IV | 5 (1.3) |
| not available | 24 (6.4) |
AJCC, American Joint Committee on Cancer; HCC, hepatocellular carcinoma; TCGA, The Cancer Genome Atlas.